- United States
- /
- Software
- /
- NasdaqGS:INTU
Intuit Affirm Partnership Tests Growth Potential After Sharp Share Price Pullback
- Intuit announced an exclusive multi year partnership with Affirm to integrate pay over time options directly into QuickBooks Payments.
- The new feature will let small and mid sized businesses offer customers buy now, pay later at checkout while receiving funds upfront.
- Affirm will take on repayment risk and handle underwriting, with no additional technical build required for QuickBooks users.
For investors watching Intuit (NasdaqGS:INTU), this move comes as the stock trades at $434.09, with a 3 year return of 3.5% and a 5 year return of 14.4%. More recently, the shares show a 20.4% decline over the past week and a 31.0% decline over both the past month and year to date, which may shape how the market reads new product announcements like this one.
The Affirm tie in pushes QuickBooks further into embedded financing tools for small businesses that struggle with cash flow and customer payment flexibility. Investors will likely focus on whether this integrated BNPL option can support user engagement and retention within Intuit's small business ecosystem over the length of the multi year agreement.
Stay updated on the most important news stories for Intuit by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Intuit.
How Intuit stacks up against its biggest competitors
Quick Assessment
- ✅ Price vs Analyst Target: At US$434.09 versus a consensus target of US$777.85, the price sits about 44% below analyst expectations.
- ✅ Simply Wall St Valuation: Simply Wall St's model flags Intuit as trading roughly 42.9% below its estimated fair value.
- ❌ Recent Momentum: The 30 day return of about 31% decline signals weak short term momentum.
Check out Simply Wall St's in depth valuation analysis for Intuit.
Key Considerations
- 📊 The Affirm partnership builds on QuickBooks Payments and could be important for how small business customers use Intuit for cash flow and checkout options.
- 📊 Keep an eye on uptake of the pay over time feature, any commentary on QuickBooks customer retention, and how this ties into Intuit's payments and revenue figures.
- ⚠️ The key risk is that BNPL adoption or economics may not offset repayment and credit costs for Affirm, which could influence how attractive the arrangement remains over time.
Dig Deeper
For the full picture including more risks and rewards, check out the complete Intuit analysis.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:INTU
Intuit
Provides financial management, payments and capital, compliance, and marketing products and services in the United States.
Outstanding track record, undervalued and pays a dividend.
Similar Companies
Market Insights
Weekly Picks

Looking to be second time lucky with a game-changing new product

Second order memory play likely to double in a year

Intuitive Machines: To The Moon and Beyond!
AppLovin’s AI Engine Is Printing Profit
Recently Updated Narratives
Poor analysis here will mislead investors

Lynas Rare Earths to Shine with 281% Future P/E Surge

Roche is a cash-generating, defensive large-cap pharma, with upside driven by pipeline execution.
Popular Narratives
QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality
NVIDIA will see a profit margin surge of 55% in the next 5 years
